BOSTON SCIENTIFIC CORPORATION Income (Loss) from Continuing Operations before Income Taxes, Domestic
BOSTON SCIENTIFIC CORPORATION (BSX) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$311.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$311.00M.
- BOSTON SCIENTIFIC CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$261.00M.
- BOSTON SCIENTIFIC CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$394.00M.
- BOSTON SCIENTIFIC CORPORATION income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$1.12B.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$311.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | -$261.00M 10-K · filed 2026-02-17 |
| 2023-12-31 | -$394.00M 10-K · filed 2026-02-17 |
| 2022-12-31 | -$1.12B 10-K · filed 2025-02-18 |
| 2021-12-31 | -$648.00M 10-K · filed 2024-02-20 |
| 2020-12-31 | -$660.00M 10-K · filed 2023-02-23 |
| 2019-12-31 | -$1.15B 10-K · filed 2022-02-23 |
| 2018-12-31 | $35.00M 10-K · filed 2021-02-23 |
| 2017-12-31 | -$408.00M 10-K · filed 2020-02-25 |
| 2016-12-31 | -$1.02B 10-K · filed 2019-02-19 |
| 2015-12-31 | -$1.62B 10-K · filed 2018-02-20 |
| 2014-12-31 | -$1.26B 10-K · filed 2017-02-23 |
| 2013-12-31 | -$774.00M 10-K · filed 2016-02-24 |
| 2012-12-31 | -$1.26B 10-K · filed 2015-02-25 |
| 2011-12-31 | -$437.00M 10-K · filed 2014-02-26 |
| 2010-12-31 | -$1.91B 8-K · filed 2013-05-29 |
| 2009-12-31 | -$1.10B 10-K · filed 2012-02-17 |
| 2008-12-31 | -$3.02B 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |